Rapid screening of commercially available herbal products for the inhibition of major human hepatic cytochrome P450 enzymes using the N-in-one cocktail

References

• Barnes P, Bloom B, Nahin R. (2008). Complementary and alternative medicine se among adults and children: United States, 2007. National Health Statistics Report. Washington, DC: US Department of Health and Human Services.
   Google Scholar
• Bradford M. (1976). A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein–dye binding. Analyt Biochem. 72:248–54.
   PubMed Web of Science ®Google Scholar
• Budzinski JW, Foster B, Vandenhoek S, Arnason J. (2000). An in vitro evaluation of human cytochrome P450 3A4 inhibition by selected commercial herbal extracts and tinctures. Phytomedicine. 7:273–82.
   PubMed Web of Science ®Google Scholar
• Chatterjee P, Franklin M. (2003). Human cytochrome P450 inhibition and metabolic-intermediate complex formation by goldenseal extract and its methylenedioxyphenyl components. Drug Metab Disposit. 31:1391–7.
   PubMed Web of Science ®Google Scholar
• Eisenberg DM, Davis RB, Ettner SL. (1998). Trends in alternative medicine use in the United States, 1990–1997: results of a follow-up national survey. J Am Med Assoc. 280:1569–75.
   PubMed Web of Science ®Google Scholar
• Foster B, Vandenhoek S, Hana J, Krantis A, Akhtar M, Bryan M, Budzinski J, Ramputh A, Arnason J. (2003). In vitro inhibition of human cytochrome P450-mediated metabolism of marker substrates by natural products. Phytomedicine. 10:334–42.
   PubMed Web of Science ®Google Scholar
• Gurley B, Gardner S, Hubbard M, Williams D, Gentry W, Carrier J, Khan I, Edwards D, Shah A. (2004). In vivo assessment of botanical supplementation on human cytochrome P450 phenotypes: Citrus aurantium, Echinacea purpurea, milk thistle, and saw palmetto. Pharmacokinet Drug Disposit. 76:428–40.
   Google Scholar
• Gurley B, Gardner S, Hubbard M, Williams K, Gentry W, Khan I, Shah A. (2005). In vivo effects of goldenseal, kava kava, black cohosh and valerian on human cytochrome P450 1A2, 2D6, 2E1 and 3A4 phenotypes. Clin Pharmacol Ther. 77:415–26.
   PubMed Web of Science ®Google Scholar
• Gurley B, Hubbard M, Williams D, Thaden J, Tong Y, Gentry W, Breen P, Carrier D, Cheboyina S. (2006). Assessing the clinical significance of botanical supplementation on human cytochrome P450 3A activity: Comparison of a milk thistle and black cohosh product to rifampin and clarithromycin. J Clin Pharmacol. 46:201–13.
   PubMed Web of Science ®Google Scholar
• Gurley B, Swain A, Hubbard M, Williams D, Varone G, Hartsfield F, Tong Y, Carrier D, Cheboyina S, Battu S (2008). Clinical assessment of CYP2D6-mediated herb–drug interactions in humans: effects of milk thistle, black cohosh, goldenseal, kava kava, St. John’s wort and Echinacea. Mol Nutr Food Res. 52:1–9.
   Google Scholar
• Hellum B, Nilsen O. (2008). In vitro inhibition of CYP3A4 metabolism and P-glycoprotein mediated transport by trade herbal products. Basic Clin Pharmacol Toxicol. 102:466–75.
   PubMed Web of Science ®Google Scholar
• Kay L, Kampmann J, Svendsen T, Vergman B, Hansen J, Skovsted L, Kristensen M. (1985). Influence of rifampicin and isoniazid on the kinetics of phenytoin. Br J Clin Pharmacol. 20:323–6.
   PubMed Web of Science ®Google Scholar
• Kent U, Aviram M, Rosenblat M, Hollenberg P. (2002). The licorice root derived isoflavin glabridin inhibits the activities of human cytochrome P450s 3A4, 2B6 and 2C9. Drug Metab Disposit. 30:709–15.
   PubMed Web of Science ®Google Scholar
• Lee L, Andrade A, Flexner C. (2006). Interactions between natural health products and antiretroviral drugs: pharmacokinetic and pharmacodynamic effects. Clin Infect Dis. 43:1052–9.
   PubMed Web of Science ®Google Scholar
• Lefebvre T, Foster B. (2004). In vitro activity of commercial valerian root extracts against human cytochrome P450 3A4. J Pharmacol Pharmaceut Sci. 7:265–73.
   PubMed Web of Science ®Google Scholar
• Markowitz J, Donovan J, DeVane C, Taylor R, Ruan Y, Wang J, Chavin K. (2003). Multiple doses of saw palmetto (Serona repens) did not alter cytochrome P450 2D6 and 3A4 activity in normal volunteers. Clin Pharmacol Ther. 74:536–42.
   PubMed Web of Science ®Google Scholar
• Molassiotis A, Fernadez-Ortega P, Pud D, Ozden G, Scott JA, Panteli V, Margulies A, Browall M, Magri M, Selvekerova S, Madsen E, Milovics L, Bruyns I, Gudmundsottir G, Hummerston S, Ahmad AM, Platin N, Kearney N, Patiraki E. (2005). Use of complementary and alternative medicine in cancer patients: a European survey. Ann Oncol. 16:655–63.
   PubMed Web of Science ®Google Scholar
• Ochs HR, Greenblatt DJ, Roberts GM, Dengler HJ. (1981). Diazepam interaction with antituberculosis drugs. Clin Pharmacol Ther. 29:671–78.
   PubMed Web of Science ®Google Scholar
• Pelkonen OP, Kaltiala EH, Larmi TK. I, Karki NT. (1974). Cytochrome P450-linked monooxygenase system and drug-induced spectral interactions in human liver microsomes. Chemico-Biol Interact. 9:205–16.
   PubMed Web of Science ®Google Scholar
• Scott I, Leduc R, Burt A, Marles R, Arnason J, Foster B. (2006). The inhibition of human cytochrome P450 by ethanol extracts of North American botanicals. Pharmaceut Biol. 44:315–27.
   Web of Science ®Google Scholar
• Strandell J, Neil A, Carlin G. (2004). An approach to the in vitro evaluation of potential for cytochrome P450 enzyme inhibition from herbals and other natural remedies. Phytomedicine. 11:98–104.
   PubMed Web of Science ®Google Scholar
• Tang J, Zhang J, Wu Y, Li Z. (2006). Effect of the water extract and ethanol extract from traditional Chinese medicines Angelica sinensis (oliv) diels, Ligusticum chuanxiong Hort. and Rheum palmatum L. on rat liver cytochrome P450 activity. Phytother Res. 20:1046–51.
   PubMed Web of Science ®Google Scholar
• Thomas KJ, Nicholl JP, Coleman P. (2001). Use and expenditure on complementary medicine in England: a population based survey. Complement Ther Med. 9:2–11.
   PubMed Web of Science ®Google Scholar
• Tolonen A, Petsalo A, Turpeinen M, Uusitalo J, Pelkonen O. (2007). In vitro interaction cocktail for nine major cytochrome P450 enzymes with 13 probe reactions and a single LC/MS-MS run: analytical validation and testing with monoclonal anti-CYP antibodies. J Mass Spectrom. 42:960–6.
   PubMed Web of Science ®Google Scholar
• Turpeinen M, Ghiciuc C, Opritoui M, Tursas L, Pelkonen OP, Pasanen M. (2007). Predictive value of animal models for human cytochrome P450 (CYP)-mediated metabolism: a comparative study in vitro. Xenobiotica. 37: 1367–77.
   PubMed Web of Science ®Google Scholar
• Turpeinen M, Korhonen L, Tolonen A, Uusitalo J, Juvonen R, Raunio H, Pelkonen OP. (2006). Cytochrome P450 (CYP) inhibition screening: comparison of three tests. Eur J Pharmaceut Sci. 29:130–8.
   PubMed Web of Science ®Google Scholar
• Turpeinen M, Uusitalo J, Jalonen J, Pelkonen OP. (2005). Multiple P450 substrates in a single run: Rapid and comprehensive in vitro interaction assay. Eur J Pharmaceut Sci. 24:123–32.
   PubMed Web of Science ®Google Scholar
• Unger M, Frank A. (2004). Simultaneous determination of the inhibitory potency of herbal extracts on the activity of six major cytochrome P450 enzymes using liquid chromatography/mass spectrometry and automated online extraction. Rapid Comm Mass Spectrom. 18:2273–81.
   PubMed Web of Science ®Google Scholar
• Williams J, Hyland R, Jones B, Smith D, Hurst S, Goosen T, Peterkin V, Koup J, Ball S. (2004). Drug–drug interactions for UDP-glucuronsyltransferase substrates: a pharmacokinetic explanation for typically observed low exposure (AUCl/AUC) ratios. Drug Metab Disposit. 32:1201–8.
   PubMed Web of Science ®Google Scholar
• World Health Organization (WHO). (2008). Traditional medicine. Geneva: WHO.
   Google Scholar
• Xie H, Yasar U, Lundgren S, Griskevicius L, Terelius Y, Hassan M, Rane A. (2003). Role of polymorphic human CYP2B6 in cyclophosphamide bioactivation. Pharmacogenomic J. 3:53–61.
   PubMed Web of Science ®Google Scholar
• Xue CC, Zhang A, Kin V, Da Costa C, Story D. (2007). Complementary and alternative medicine use in Australia: a national population-based survey. J Alt Complement Med. 13:643–50.
   PubMed Web of Science ®Google Scholar
• Yoo H, Lee M, Kim Y, Yun C, Kim D. (2007). Mechanism-based inactivation of cytochrome P450 2A6 by decursinol angelate isolated from Angelica gigas. Drug Metab Disposit. 35:1759–65.
   PubMed Web of Science ®Google Scholar